NasdaqGS:CERTHealthcare Services
Does Certara’s (CERT) New IQVIA-Trained CEO Mark a Strategic Shift in Its Biosimulation Focus?
Certara, Inc. has announced that Jon Resnick, a long-time IQVIA executive, will assume the roles of Chief Executive Officer and board member on January 1, 2026, succeeding Dr. William F. Feehery, whose employment and board service will end on December 31, 2025 and be treated as a termination without cause under his existing agreement.
This leadership change places a healthcare data and real-world evidence specialist at the helm, potentially influencing how Certara aligns its biosimulation...